Medicare Part D drug Data year 2024 Brand name Source: CMS Part D Prescribers

Darzalex Faspro

Daratumumab-Hyaluronidase-Fihj

Open in the dashboard

Part D claims

6,205

Prescriptions dispensed, refills included

Drug cost

$81,858,465

Paid at the pharmacy, in all

Prescribers

218

With 11 or more claims of it

In 2024, Medicare Part D recorded 6,205 claims for Darzalex Faspro (daratumumab-hyaluronidase-fihj) from 218 prescribers, at a total drug cost of $81.9 million paid at the pharmacy by Medicare, patients and others.

Where it is prescribed

By the prescriber's state · 29 states and territories
Part D claims for Darzalex Faspro by the state of the prescriber, 2024
State Relative to the most Prescribers Claims Drug cost
NY 69 1,975 $27,596,320
CA 31 761 $10,466,975
FL 29 760 $10,700,160
NJ 20 516 $6,108,279
OH 7 426 $4,081,828
PA 9 258 $3,026,359
LA 2 213 $3,551,646
AR 8 202 $1,951,885
ME 4 169 $1,606,908
HI 4 104 $1,471,905
TN 3 100 $1,121,759
MA 4 96 $988,808
TX 4 87 $1,699,890
AL 2 82 $1,069,671
VI 2 68 $681,408
The other 14 states and territories
State Prescribers Claims Drug cost
NC 2 57 $926,660
MD 2 42 $722,986
NV 3 37 $626,226
KY 1 29 $532,151
WA 1 28 $283,236
VA 2 28 $270,755
AZ 1 25 $236,238
OK 2 25 $478,311
PR 1 24 $320,777
DC 1 23 $458,917
ID 1 23 $427,096
IL 1 19 $183,624
IA 1 16 $153,319
NH 1 12 $114,365

The state is where the prescriber practices, not where the patient lives. Totals are Medicare Part D claims only.

Which specialties prescribe it

Top 11 of 11
Part D claims for Darzalex Faspro by prescriber specialty, 2024
Specialty Relative to the most Prescribers Claims Drug cost
Hematology-Oncology 165 4,870 $64,947,696
Medical Oncology 27 713 $9,105,200
Hematology 7 212 $2,976,162
Internal Medicine 8 208 $2,235,438
Nurse Practitioner 5 106 $1,041,622
General Practice 1 26 $487,277
Hospitalist 1 18 $236,240
Physician Assistant 1 15 $234,229
Specialist 1 14 $124,948
Radiation Oncology 1 12 $359,163
Geriatric Medicine 1 11 $110,491

Specialty is the one printed on each prescriber's Medicare claims.

Largest prescribers

First 5 of 100 by claims · 2024

Two separate records. Claims come from Medicare and related payments from Open Payments. They are shown in one row because they name the same product; they do not show that a payment affected a prescription.

The prescribers with the most Part D claims of this drug in 2024
Prescriber Specialty State Claims Drug cost Related payments
Kirtan Koticha Hematology-Oncology LA 178 $2,886,783 $78
Sanaullah Khalid Hematology-Oncology OH 141 $1,344,953 $11
Ivette Vigoda Hematology-Oncology NY 82 $752,162 $119
Thomas Blom Hematology-Oncology NJ 79 $740,717 None on record
Roger Hakimian Hematology-Oncology OH 75 $717,797 $43

"No profile" means the prescriber has no Open Payments record here; "None on record" means no payment naming this product in the payment year. Related payments are general payments, and one that names several products is split evenly, so an amount is payments related to the product, not money paid for it. The list is the prescribers with the most claims, up to 100 per drug.

See more in the dashboard: 25 with a free account, all 100 with Patron

Industry payments naming this drug

From CMS Open Payments

Open Payments names products as manufacturers reported them, and CMS does not link them to Part D drugs, so this match is by name and ours. The two records are separate: they do not show that a payment affected a prescription.

What this means

Medicare Part D is the part of Medicare that covers prescription drugs dispensed at a pharmacy. Each year CMS publishes, for every prescriber and drug, how many claims were dispensed and what they cost. This page adds those up for one drug.

A claim is one prescription filled, refills included. Drug cost is the total paid at the pharmacy by Medicare, the patient and anyone else; it is not money to the prescriber. CMS leaves out any prescriber with fewer than 11 claims of a drug, so the prescriber count is a floor and a missing prescriber does not mean none.

Part D covers drugs dispensed to Medicare beneficiaries at a pharmacy. It does not include drugs given in a clinic or hospital, patients with other insurance, or the most recent year, which Medicare publishes about two years behind.

Provenance

Source: CMS Medicare Part D Prescribers by Provider and Drug · data year 2024

We reproduce what CMS published. We do not verify, edit or correct the underlying records.

A prescription record is not evidence of wrongdoing, and nothing here is medical advice. Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency.

How to dispute or correct a record